Mycoplasma Testing Market is Expected to Witness Speedy Growth of USD 1.59 Billion by 2027 | Reports and Data

According to the current analysis of Reports and Data, the global Mycoplasma Testing market was valued at USD 609.39 Million in 2019 and is expected to reach USD 1.59 Billion by year 2027, at a CAGR of 12.6%. Mycoplasma is the smallest discovered species of bacteria, mostly developed through the de-generative evolution from Gram-positive bacteria. Mycoplasma bacterial cell lacks a cell wall and can either be parasitic or saprotrophic. Though, there are around 200 different types of mycoplasma bacteria, most of them are harmless. Only 5 out of 200 cause severe infections in humans, which include Mycoplasma pneumonia, Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma parvum. Different species of mycoplasma cause different diseases in the human body. For example, Mycoplasma pneumonia affects the throat and lungs, while Mycoplasma genitalium is associated with urethra infection. Mycoplasma testing is used to diagnose present or past mycoplasma infection in patients. Mycoplasma microbes can exist as healthy flora in the patient's throat, genitourinary tract, or respiratory tract.

Additionally, due to the lack of cell wall, the mycoplasma bacterial cells are immune to a several common antibiotics. Furthermore, mycoplasma testing plays an essential role in cell culture and must be done at every step of product development, including cell banks, viral seed stocks, and final products. The mycoplasma testing market is majorly driven by significant research and development activities in academia as well as the bio-pharmaceutical industry, increasing incidences of mycoplasma infections, and cell culture contamination. Mycoplasma can quickly spread through droplets during cell culture and are difficult to detect under a microscope; hence, they need specific tests to be performed for the same. Growing expenditure in the healthcare sector by key market players to enhance customer satisfaction and achieve technological advancements is expected to propel the global market for mycoplasma testing. Mycoplasma testing market is also driven by the increased adoption of mycoplasma testing in the microbiology sector, rising occurrences of mycoplasma infections, growing number of water pollution-related infections, favorable investment scenario for the healthcare industry through public and private sector, and increasing awareness about mycoplasma bacterial infections. However, lack of awareness of mycoplasma infection among patients & clinicians, and challenges related to its detection are expected to hinder the market growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2129

Further key findings from the report suggest:

Mycoplasma testing market is growing at a CAGR of 13.0% in Asia Pacific, followed by North America and Europe, with 12.8 % and 12.5% CAGR respectively. Increasing government support, coupled with high investments in R&D, is a major factor driving the market growth.
As of 2019, Kits & Reagents segment is the dominating Mycoplasma testing, which holds 47.5% of the global market. The Asia Pacific regional market is the chief revenue generating source for this product segment, followed by the North American and European regions.

Mycoplasma infection is one of the major cause of human infectious diseases, therefore the sample requires to be tested at every step of processing.
The absence of a cell wall allows the mycoplasma bacteria to enter the white blood corpuscles (WBCs), which makes it almost impossible to kill these bacteria once they hide in the immune system.

As mycoplasma infection can become chronic, it reduces the efficiency and strength of the immune system, making it weak over time and highly increasing the risk of infections caused by other microorganisms.

Mycoplasma contamination is the most common but serious problem faced while culturing cells, thus proper mycoplasma testing should be carried out before production of the final product. For instance, the MycoProbe Mycoplasma Detection Kit can be used for high-throughput and routine screening of cell culture for detection of mycoplasma contamination.

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Mycoplasma Testing market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Norgen Biotek Corp. (Canada), GenBio (Canada), Meridian Bioscience, Inc. (U.S.), and Savyon Diagnostics (Israel).

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2129

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Mycoplasma Testing Market Segmentation:

Product Type (Revenue, USD Million; 2017-2027)

Instruments
Kits & Reagents
PCR Assay
Nucleic Acid Detection
Elimination Kits & Reagent
Stains
Standards & Controls
Others
Services
Others

Technology Type (Revenue, USD Million; 2017-2027)

PCR
ELISA
Direct Assay
Indirect Assay
DNA Staining
Microbial Culture Techniques
Enzymatic Methods
Others

Application Type (Revenue, USD Million; 2017-2027)

Cell Line Testing
Virus Testing
End of Production Cells Testing
Others

End Use (Revenue, USD Million; 2017-2027)

Pharmaceutical Companies
Cell Banks
Others

Geographic Segment Covered in the Report:

The Mycoplasma Testing report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)

Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/mycoplasma-testing-market

Key market aspects are illuminated in the report:

Executive Summary: It covers a summary of the most vital studies, the Global Mycoplasma Testing market increasing rate, market trends, drivers and problems as well as macroscopic pointers.

Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Mycoplasma Testing market, the years measured, and the study points.

Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.

Manufacture by Region: This Global Mycoplasma Testing report offers data on imports and exports, sales, production and key companies in all studied regional markets.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2129

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Binge Eating Disorder Treatment Market @ https://www.biospace.com/article/binge-eating-disorder-treatment-market-seeking-excellent-growth-by-2030-reports-and-data/

Peripheral Nerve Injury Market @ https://www.biospace.com/article/peripheral-nerve-injury-market-to-exhibit-growth-at-a-steady-pace-through-2030-reports-and-data/

Nutrigenomics Market @ https://www.biospace.com/article/nutrigenomics-market-size-worth-usd-1-289-7-million-in-2028-emergen-research/

Sepsis Diagnostics Market @ https://www.biospace.com/article/sepsis-diagnostics-market-to-reach-usd-841-58-million-by-2027-at-a-cagr-of-9-percent-reports-and-data/

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.